Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ==Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1== | + | ==Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1 <ref>PMID:41168207</ref>== |
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| Line 7: | Line 7: | ||
== Disease == | == Disease == | ||
| - | RIPK1 has been reported to be involved in many neurodegenerative diseases such as AD, ALS and MS. In Alzheimer's disease, it has been shown to regulate microglial function by modulating cell inflammation <ref>PMID:28904096< | + | RIPK1 has been reported to be involved in many neurodegenerative diseases such as AD, ALS and MS. In Alzheimer's disease, it has been shown to regulate microglial function by modulating cell inflammation <ref>PMID:28904096</ref>. In Amyotrophic Lateral Sclerosis, RIPK1, along with RIPK3 and MLKL, has been shown to contribute to the demyelination and degeneration of neurons <ref>PMID:27493188/<ref>. |
| - | RIPK1 was also linked to an auto-inflammatory syndrome, CRIA syndrome. It is caused by a mutation in RIPK1, which prevents it from being cleaved, leading to uncontrolled cell death and chronic inflammation <ref>PMID:31827281< | + | RIPK1 was also linked to an auto-inflammatory syndrome, CRIA syndrome. It is caused by a mutation in RIPK1, which prevents it from being cleaved, leading to uncontrolled cell death and chronic inflammation <ref>PMID:31827281</ref>. |
== Structural Determination == | == Structural Determination == | ||
Revision as of 10:10, 29 November 2025
Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1 [1]
| |||||||||||
References
- ↑ Polonio P, López-Alonso JP, Jiang H, Andrés-Campos S, Escobedo-González FC, Titaux-Delgado GA, Ubarretxena-Belandia I, Mompeán M. Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1. Nat Commun. 2025 Oct 30;16(1):9607. PMID:41168207 doi:10.1038/s41467-025-64621-6
- ↑ Ofengeim D, Mazzitelli S, Ito Y, DeWitt JP, Mifflin L, Zou C, Das S, Adiconis X, Chen H, Zhu H, Kelliher MA, Levin JZ, Yuan J. RIPK1 mediates a disease-associated microglial response in Alzheimer's disease. Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8788-E8797. PMID:28904096 doi:10.1073/pnas.1714175114
- ↑ PMID:27493188/<ref>. RIPK1 was also linked to an auto-inflammatory syndrome, CRIA syndrome. It is caused by a mutation in RIPK1, which prevents it from being cleaved, leading to uncontrolled cell death and chronic inflammation <ref>PMID:31827281</li></ol></ref>
